A Study to Evaluate the Effect of Sarpogrelate on Blood Hyperviscosity

Clinical trial NCT03509922 · COMPLETED

Trial details

NCT number: NCT03509922
Sponsor: Yuhan Corporation
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Peripheral Artery Disease, PAD

Start date: 2018-10-11
Primary completion: 2019-12-26
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.